VILLENEUVE D'ASCQ, France, April 13, 2011 /PRNewswire/ -- Osyris Medical, a leading laser medical company, announced today results for the three months ended March 31, 2011. Revenues for the first quarter of 2011 increased 49.3 percent in the corresponding consolidation perimeter and period of 2010, primarily as a result of increased international sales. This trend of sales, on top of the restructuring operations which took place in 2010 enhances significantly the EBITDA, and increase profitability during the first quarter.
The recent FDA clearance of Lipocontrol dated January 21st appears to have a considerable impact on the company increasing revenues. Clinical studies provided to the FDA were showing a better control of energy delivery, while limiting the risk of accidental use of the laser. The Lipocontrol has been received well by the global market, and first devices been already shipped and installed.
Dr. Vivek Bansal of EliteMD Advanced Dermatology, Laser & Plastic Surgery in Danville, CA reports: "Lipocontrol offers an advanced level of safety for the physician and the patient in laser lipolysis that will enhance patient results."
Dr. Kavali of Kavali Plastic Surgery and Skin Renewal Center in Atlanta, GA said: "Lipocontrol is the perfect name for this device, because it truly gives the surgeon precise control over energy application for laser lipolysis. With Lipocontrol, I've found more treatment efficiency without sacrificing any treatment efficacy."
"We believe the increase sales validates our strategy of forging new distributor relationships in emerging overseas markets such as Asia, Middle East and South America" said Osyris Medical Sales Director Franck Monnet. "During the last 6 months, Osyris Medical has worked hard to develop its overseas distribution network. New distribution agreements have been signed in South Korea, Thailand, Vietnam, Kuwait and Gulf countries, Lebanon, Syria, Jordania, Mexico, where the company whishes now to establish its brand as a standard of quality."
About Osyris Medical
Based in Lille, France, Osyris Medical is a leading manufacturer for producing emerging technologies within a specific market. The company is internationally recognized for its scientific vision and its R&D capacity to bring innovation on the market. Part of the company activity focuses on skin tightening, body contouring and vein removal procedures that are scientifically proven, clinically validated and has high consumer demand. For more information, please visit: http://www.osyrismedical.com
For further information, please contact: [email protected]
SOURCE Osyris Medical